2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.

S

Predictors of 30-day readmissions after catheter ablation for atrial fibrillation in the USA.

BACKGROUND: Catheter ablation is considered as the mainstay treatment for patients with symptomatic atrial fibrillation (AF). We aimed to determine the predictors of 30-day readmission after catheter ablation for AF. METHODS: The study cohort consisted of patients who underwent AF catheter ablation (International Classification of Diseases, Ninth Revision 427.31 and procedure code 37.34) in 2014, identified from the National Readmission Database. RESULTS: Our final cohort consisted of 5322 unweighted cases, of which 4736 (89%) constituted the no-readmission group and 586 patients (11%) the readmission group. Female gender (OR 1.62, 95% CI 1.35-1.95), CAD (OR 1.36, 95% CI 1.08-1.71), peripheral vascular disease (OR 1.45, 95% CI 1.07-1.98), acute renal failure (OR 1.46, 95% CI 1.09-1.97), fluid and electrolyte disorders (OR 1.32, 95% CI 1.03-1.67), chronic pulmonary disease (OR 1.25, 95% CI 1.01-1.53), ablation on the day of admission (OR 0.74, 95% CI 0.61-0.91), and fourth quartile of hospital AF catheter ablation volume (OR 0.60, 95% CI 0.45-0.80) were independent predictors of 30-day readmission. Arrhythmias and heart failure were the most common cardiac etiologies for readmission. The most common ablation-related complications were hemorrhage (11%) and vascular (7%) complications. CONCLUSIONS: Several patient- and hospital-related factors were identified as predictors of 30-day readmission, the knowledge of which can potentially improve healthcare delivery

Thirty-Day Readmissions After Cardiac Implantable Electronic Devices in the United States: Insights from the Nationwide Readmissions Database.

BACKGROUND: Limited data are available regarding true estimates of individual complications contributing to readmissions after cardiac implantable electronic device (CIED) implantation. OBJECTIVE: We aimed to identify predictors of 30-day readmission in patients admitted for CIED implantation. METHODS: The study cohort consisted of patients who received CIED implantation in 2014, identified from National Readmission Database. Readmission was defined as a subsequent hospital admission within 30 days after discharge day of index admission. If patients had more than one readmission within 30 days, only the first readmission was included. RESULTS: Our final cohort consisted of 70,223 cases, of which 61,738 (88%) in no-readmission and 8,485 patients (12%) in readmission group. Female gender (OR 1.09, 95%CI: 1.04-1.14; p=0.001), atrial fibrillation/flutter (OR 1.23, 95%CI: 1.17-1.29, p CONCLUSION: Several patient and hospital-related factors were identified to be independent predictors of 30-day readmission, accounting for increased healthcare cost